Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome
Latest Information Update: 20 Feb 2023
Price :
$35 *
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms CCC-ACS
- 02 Feb 2023 Results evaluating association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome , published in the European Journal of Medical Research
- 08 Nov 2022 Results (n=40670) assessing risk factors of STEMI patients with in-hospital cardiac arrest published in the Journal of the American College of Cardiology
- 01 Nov 2022 Results(n=18,244 ) comparing the in-hospital outcomes of ticagrelor versus clopidogrel in older patients with acute coronary syndrome published in the Age and Ageing